‘Aatma Nirbhar Bharat’ is some Music to Domestic Medical Device Industry

New Delhi: At long last, ‘Make in India’ music has lyrics in it for domestic medical device industry. The modification in public procurement norms has it in glee and going gaga over the govt’s earnest ‘Aatma Nirbhar Bharat’ move. This will entail preference to domestic companies.

This move will facilitate give maximum preference to local companies whose goods and services have 50 per cent or more local content. The step of modification of rules has been taken to make the country self-reliant in medical devices.

“We on behalf of the Indian Medical Devices industry welcome this strategic move by the Govt. While there is still no price preference advantage for Global Tender but Preference of qty is now available to class 1 local supplier with over 50% domestic content & not to class 2 local supplier with 20-50% local content.” Said Mr. Rajiv Nath, Forum Coordinator, AiMeD.

The Department for Promotion of Industry and & Internal Trade has amended its Public Procurement (Preference to Make In India) Order of 2017 that gives priority to bidders of government contracts that use more local content. The revised order has introduced a concept of Class-I, II and non-local suppliers, based on which they will get preference in government purchases of goods and services. Class-I local suppliers will get the most preference in all government purchases because their domestic value local content addition is 50 percent or more. They will be followed by Class-II suppliers, whose local content value addition range is more than 20 percent but less than 50 percent.

Companies with less than 20 per cent of domestic content in their goods or services will not able to participate in most of the government tenders and they are categorized as “non-local suppliers”.

Mr. Rajiv Nath said “The good news is that below Rs. 200 Crore tender which is usually the case of most Medical Device tenders, only Indian manufacturer are eligible to participate (with at least 20% domestic content) and if there is adequate capacity & competitiveness then the participation will be reserved for Domestic Manufacturers with over 50% Domestic Content.  This is definitely a ‘Make in India’ enabler.”

“If there are not many Indian manufacturers then a global tender will need to be issued but only with permission of the Secretary. Key issue is Govt. needs to ensure that concessional 20% domestic value should be at least from assembly of Indian parts /materials, not salaries & marketing overheads or India will start promoting pseudo manufacturing which like termites has been undermining effort of sincere manufacturers, we want that these fence sitters actually manufacture in India instead of pretending to be one . GeM also needs to urgently list all manufacturers on basis of domestic content: > 20% , > 50% domestic content or as non local supplier to aid buyers and enable make in India.” Added Mr. Nath.

For verification of local content, the Class I and II suppliers shall be required to indicate percentage of local content and provide self-certification that the item offered meets the local content requirement norms. Concept of Class-I supplier has been introduced so that in cases where local suppliers are to be given the order, even within that group we should give first preference to the ones whose domestic value addition is significantly high.

The India Medical Devices industry is happy that now domestic will be preferred over foreigner wherever possible. Under the Public Procurement (Preference to Make in India) Order, it was envisaged that all central government departments, their attached or subordinate offices and autonomous bodies controlled by the Government of India should ensure that purchase preference will be given to domestic suppliers. India imports over 80% of its requirements of medical devices worth over 42000Cr Rs of and the Institutional Govt Sales are estimated to be over 25,000 Cr Rs.

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case